Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia

NCT05851027 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Thrombocytopenia

Interventions

DRUG: QL0911

Sponsor

Qilu Pharmaceutical Co., Ltd.